Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice
Hanseul Yang, … , Gou Young Koh, Injune Kim
Hanseul Yang, … , Gou Young Koh, Injune Kim
Published December 17, 2012
Citation Information: J Clin Invest. 2013;123(1):418-431. https://doi.org/10.1172/JCI64547.
View: Text | PDF
Research Article Oncology

Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice

Abstract

Little is known about the transcriptional regulation of tumor angiogenesis, and tumor ECs (tECs) remain poorly characterized. Here, we studied the expression pattern of the transcription factor Sox17 in the vasculature of murine and human tumors and investigated the function of Sox17 during tumor angiogenesis using Sox17 genetic mouse models. Sox17 was specifically expressed in tECs in a heterogeneous pattern; in particular, strong Sox17 expression distinguished tECs with high VEGFR2 expression. Whereas overexpression of Sox17 in tECs promoted tumor angiogenesis and vascular abnormalities, Sox17 deletion in tECs reduced tumor angiogenesis and normalized tumor vessels, inhibiting tumor growth. Tumor vessel normalization by Sox17 deletion was long lasting, improved anticancer drug delivery into tumors, and inhibited tumor metastasis. Sox17 promoted endothelial sprouting behavior and upregulated VEGFR2 expression in a cell-intrinsic manner. Moreover, Sox17 increased the percentage of tumor-associated CD11b+Gr-1+ myeloid cells within tumors. The vascular effects of Sox17 persisted throughout tumor growth. Interestingly, Sox17 expression specific to tECs was also observed in highly vascularized human glioblastoma samples. Our findings establish Sox17 as a key regulator of tumor angiogenesis and tumor progression.

Authors

Hanseul Yang, Sungsu Lee, Seungjoo Lee, Kangsan Kim, Yeseul Yang, Jeong Hoon Kim, Ralf H. Adams, James M. Wells, Sean J. Morrison, Gou Young Koh, Injune Kim

×

Figure 3

Sox17 deletion in tECs reduces tumor angiogenesis and vascular abnormalities.

Options: View larger image (or click on image) Download as PowerPoint
Sox17 deletion in tECs reduces tumor angiogenesis and vascular abnormal...
Tumor vessels were analyzed in LLC tumors grown in control and Sox17iΔEC mice. (A) Images of tumor vessels. (B) Filopodial protrusions, indicated by yellow arrows on the outside surfaces of tumor vessels. (C) Dextran release from the tumor vessels. (D) VE-cadherin staining of tumor vessels. (E) Col4 staining showing the basement membrane in tumor vessels. (F) α-SMA staining showing pericytes in tumor vessels. Higher-magnification images are shown below to better visualize the association of pericytes and endothelium. (G and H) Quantitation of blood vessel (BV) density and branches in tumors. (I) Quantitation of filopodial extensions on tumor vessels. (J) Quantitation of extravasated Evans blue in tumors. (K and L) Quantitation of tumor vessels surrounded by Col4 matrix and α-SMA+ pericytes. (A–F) Scale bars: 100 μm. (G–L) n = 3 per group. *P < 0.01 versus control.